A

Adaptimmune Therapeutics plc
D

ADAP

0.25130
USD
0.01
(4.62%)
مغلق
حجم التداول
3,817
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
66,607,465
أصول ذات صلة
L
LYFT
0.390
(2.48%)
16.100 USD
P
PTON
0.03500
(0.53%)
6.64000 USD
ROKU
ROKU
1.780
(2.06%)
88.160 USD
SNAP
SNAP
-0.14000
(-1.49%)
9.24000 USD
SPOT
SPOT
15.27
(2.15%)
724.20 USD
TTD
TTD
0.690
(0.94%)
74.270 USD
ZM
ZM
1.010
(1.30%)
78.570 USD
المزيد
الأخبار المقالات

العنوان: Adaptimmune Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.